Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Revenue (2011 - 2026)

Updated

Adma Biologics (ADMA) posted Revenue of $124.4 million for Q2 2026, up 2.0% from $121.98 million a year earlier and up 8.6% from the prior quarter.

Analysis

Adma Biologics (ADMA) Revenue (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Adma Biologics was $512.28 million, up 8.0% year-over-year; for FY2025, it came in at $510.17 million, up 19.6% from FY2024.

  • Annual Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 64.6% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Revenue was $426.45 million in FY2024 (+65.2%), $258.22 million in FY2023 (+67.6%), $154.08 million in FY2022 (+90.4%) and $80.94 million in FY2021 (+91.7%).
  • Quarterly Revenue has run from a low of $20.68 million in Q3 2021 to a high of $139.16 million in Q4 2025 over five years.
  • On a year-over-year basis, Revenue increased in seven of the last eight quarters, with growth averaging 27.9%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q3 2021, with growth of 101.2%; the weakest was Q1 2026, with a decline of 0.3%.
  • According to Business Quant data, Revenue for the three prior quarters was $114.49 million (Q1 2026), $139.16 million (Q4 2025) and $134.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 124.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.40 Mn
Mar 31, 2026 114.49 Mn
Dec 31, 2025 139.16 Mn
Sep 30, 2025 134.22 Mn
Jun 30, 2025 121.98 Mn
Mar 31, 2025 114.80 Mn
Dec 31, 2024 117.55 Mn
Sep 30, 2024 119.84 Mn
Jun 30, 2024 107.19 Mn
Mar 31, 2024 81.88 Mn
Dec 31, 2023 73.90 Mn
Sep 30, 2023 67.28 Mn
Jun 30, 2023 60.12 Mn
Mar 31, 2023 56.91 Mn
Dec 31, 2022 49.98 Mn
Sep 30, 2022 41.09 Mn
Jun 30, 2022 33.91 Mn
Mar 31, 2022 29.10 Mn
Dec 31, 2021 26.38 Mn
Sep 30, 2021 20.68 Mn
API Access

Adma Biologics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEY